OKYO Pharma's OK-101: A Revolutionary Treatment for Dry Eye Disease. Dry Eye Disease (DED) is a prevalent condition affecting millions globally, characterized by discomfort, visual disturbance, and potential damage to the ocular surface. Despite the availability of various treatments, many patients continue to seek more effective solutions. In a significant development, OKYO Pharma has announced that its drug, OK-101, has achie...
$OKYO Pharma(OKYO.US)$OKYO Pharma Says OK-101 Achieves Statistical Significance For Multiple Signs And Symptoms Of Dry Eye Disease Including Ocular Pain Relief In Its First-in-Human Phase 2 Trial Of OK-101
OKYO Pharma股票討論區
Dry Eye Disease (DED) is a prevalent condition affecting millions globally, characterized by discomfort, visual disturbance, and potential damage to the ocular surface. Despite the availability of various treatments, many patients continue to seek more effective solutions. In a significant development, OKYO Pharma has announced that its drug, OK-101, has achie...
暫無評論